ANAC
Goldman Sachs’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,561,729
| Closed | -$83.5M | – | 4845 |
|
|
2016
Q1 | $83.5M | Buy |
1,561,729
+1,176,583
| +305% | +$62.9M | 0.03% | 648 |
|
|
2015
Q4 | $43.5M | Buy |
385,146
+275,228
| +250% | +$31.1M | 0.01% | 969 |
|
|
2015
Q3 | $12.9M | Buy |
109,918
+97,306
| +772% | +$11.5M | ﹤0.01% | 1512 |
|
|
2015
Q2 | $976K | Sell |
12,612
-47,434
| -79% | -$3.67M | ﹤0.01% | 2965 |
|
|
2015
Q1 | $3.47M | Buy |
60,046
+37,293
| +164% | +$2.16M | ﹤0.01% | 2228 |
|
|
2014
Q4 | $734K | Sell |
22,753
-47,924
| -68% | -$1.55M | ﹤0.01% | 3128 |
|
|
2014
Q3 | $1.73M | Buy |
70,677
+19,287
| +38% | +$472K | ﹤0.01% | 2594 |
|
|
2014
Q2 | $911K | Buy |
+51,390
| New | +$911K | ﹤0.01% | 3016 |
|
|
2014
Q1 | – | Sell |
-11,063
| Closed | -$186K | – | 4539 |
|
|
2013
Q4 | $186K | Buy |
+11,063
| New | +$186K | ﹤0.01% | 3913 |
|
|
2013
Q3 | – | Sell |
-13,735
| Closed | -$77K | – | 4391 |
|
|
2013
Q2 | $77K | Buy |
+13,735
| New | +$77K | ﹤0.01% | 3838 |
|